Thalidomide: a step forward in the treatment of malignant monoclonal gammopathies

Clin Lymphoma. 2003 Mar;3(4):247-8. doi: 10.1016/s1526-9655(11)70186-5.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Amyloidosis / drug therapy
  • Amyloidosis / immunology
  • Humans
  • Immunoglobulin kappa-Chains / immunology
  • Immunoglobulin lambda-Chains / immunology
  • Immunosuppressive Agents / administration & dosage*
  • Paraproteinemias / drug therapy*
  • Paraproteinemias / immunology
  • Thalidomide / administration & dosage*

Substances

  • Immunoglobulin kappa-Chains
  • Immunoglobulin lambda-Chains
  • Immunosuppressive Agents
  • Thalidomide